Related Experiment Video
Updated: Mar 29, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
451
LUNG CANCER AND PULMONARY THROMBOEMBOLISM
1Clinic for pulmonary diseases and TB "Podhrastovi", Clinical centre of Sarajevo University, Bosnia and Herzegovina.
Materia Socio-Medica
|December 2, 2015
Summary
Lung cancer significantly increases the risk of pulmonary thromboembolism (PTE). This study found 2.61% of lung cancer patients developed PTE, highlighting the need for anticoagulant prophylaxis.
Area of Science:
- Pulmonary Medicine
- Oncology
- Cardiology
Background:
- Malignant diseases, particularly lung cancer, are established risk factors for developing pulmonary thromboembolism (PTE).
- Understanding the incidence of PTE in lung cancer patients is crucial for risk stratification and management.
Purpose of the Study:
- To determine the incidence of pulmonary thromboembolism (PTE) among patients diagnosed with lung cancer.
- To analyze the occurrence of PTE in relation to specific histological types of lung cancer.
- To assess the proportion of lung cancer-associated PTE within the overall PTE cases at the clinic.
Main Methods:
- A retrospective study was conducted analyzing patient data from 2012-2014.
- Data collected included the number of lung cancer patients, the incidence of PTE in this cohort, and the types of lung cancer.
- The study also examined the proportion of PTE cases attributable to lung cancer among all PTE diagnoses.
Main Results:
- A total of 1609 lung cancer patients were treated between 2012 and 2014.
- Pulmonary thromboembolism (PTE) was diagnosed in 42 patients (2.61% of lung cancer patients).
- Histologically non-differentiated lung carcinoma was most frequently associated with PTE (45.24%), followed by adenocarcinoma (21.43%).
Conclusions:
- Lung cancer is a significant risk factor for pulmonary thromboembolism (PTE).
- The findings underscore the importance of considering anticoagulant prophylaxis in lung cancer patients to mitigate PTE risk.
- Early detection and management of PTE in lung cancer patients can potentially improve outcomes.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
01:27Pulmonary Embolism III: Nursing Management
658
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
658
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
656
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
656
01:17Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
01:30Venous Thrombosis I: Introduction
690
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
690